Glioblastoma models driven by different mutations converge to the proneural subtype.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 01 2020
Historique:
received: 18 07 2019
revised: 29 10 2019
accepted: 07 11 2019
pubmed: 17 11 2019
medline: 20 6 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

The need of reliable syngeneic animal models for gliomas has been addressed in the last decades by reproducing genetic alterations typical of human glioblastoma in the mouse. Since different alterations underlie different molecular glioblastoma subtypes it is commonly expected that tumors induced by specific alterations represent models of the corresponding subtypes. We tested this assumption by a multilevel analysis ranging from a detailed histopathological analysis to a genome-wide expression profiling by microarray and RNA-seq on gliomas induced by two distinct molecular alterations: the overstimulation of the PDGF- and the EGF- pathways. These alterations are landmarks of proneural and classical glioblastoma subtypes respectively. However, our results consistently showed a strong similarity between the two glioma models. The expression profiles of both models converged toward a signature typical of oligodendrocyte progenitor cells, regardless the wide differentiative potential of the cell of origin. A classification based on similarity with human gliomas profiles revealed that both models belong to the proneural subtype. Our results highlight that reproducing a molecular alteration specific of a glioblastoma subtype not necessarily generates a tumor model recapitulating such subtype.

Identifiants

pubmed: 31733287
pii: S0304-3835(19)30565-8
doi: 10.1016/j.canlet.2019.11.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-455

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Francesco Alessandrini (F)

Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.

Davide Ceresa (D)

Department of Experimental Medicine, University of Genoa, Genoa, Italy.

Irene Appolloni (I)

Department of Experimental Medicine, University of Genoa, Genoa, Italy.

Francesca Pagani (F)

Department of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.

Pietro Luigi Poliani (PL)

Department of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.

Daniela Marubbi (D)

Ospedale Policlinico San Martino, IRCCS, Genoa, Italy; Department of Experimental Medicine, University of Genoa, Genoa, Italy.

Paolo Malatesta (P)

Ospedale Policlinico San Martino, IRCCS, Genoa, Italy; Department of Experimental Medicine, University of Genoa, Genoa, Italy. Electronic address: paolo.malatesta@unige.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH